Connect with us

Psychedelics

The Oregon Psilocybin Services Community Interest Survey, “the Oregon Health Authority is conducting a survey to better understand who may be interested in accessing psilocybin services”

Published

on


Greetings!

The Oregon Psilocybin Services Section within the Oregon Health Authority is conducting a survey to better understand who may be interested in accessing psilocybin services, service center licensure, facilitator licensure, manufacturer licensure, testing lab licensure, and/or training program approval.

The survey is anonymous and will take about five to ten minutes to complete. The survey will close at 11:59 p.m. PST on February 6, 2022.

Will you please distribute this information and survey links via your distribution lists?

The survey can be completed using the links below (or the attached PDF documents):

Thank you for participating in the survey!



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Psychedelics

Rapper arrested at airport with liquid LSD and Psilocybin capsules, gummies and mushrooms

Published

on

By


He obviously wasn’t leaving anything out of his goodie bag!

Authorities arrested rapper Vic Mensah at Washington Dulles International Airport after U.S. Customs and Border Protection said its officers found a cache of illicit narcotics in his baggage.

Victor Kwesi Mensah, 28, arrived on a flight from Ghana around 7 a.m. Saturday. During a secondary baggage examination, CBP said its officers discovered about 41 grams of liquid LSD, about 124 grams of Psilocybin capsules, 178 grams of Psilocybin gummies and six grams of Psilocybin mushrooms concealed inside Mensah’s luggage.

Metropolitan Washington Airport Authority police officers charged Mensah with felony narcotics possession charges and took custody of Mensah and the drugs.

CBP warns travelers that narcotics possession remains illegal under federal law, and travelers are subject to CBP federal inspection upon departing and arriving to the United States.

https://www.wbaltv.com/article/rapper-vic-mensah-arrested-dulles-drug-charges/38796398#



Source link

Continue Reading

Psychedelics

Press Release: Telescope Files Patent Cooperation Treaty Application on Scalable Psilocybin and Tryptamine Synthesis

Published

on

By


VANCOUVER, BC / ACCESSWIRE / January 17, 2022 / Telescope Innovations Corp. (“Telescope” or the “Company“) (CSE:TELI) announces that it has filed a Patent Cooperation Treaty (“PCT“) patent application for its scalable manufacturing methods to produce psilocybin and related tryptamine compounds. This application claims the priority date of a preceding provisional application filed with the United States Patent and Trade Office on December 31, 2020.

This PCT filing covers novel synthetic routes for the production of psilocybin and psilocin along with their precursors, analogs, and derivatives. These molecules belong to the tryptamine class of compounds that has been gaining momentum in the psychedelic medicine space in recent years. The processes outlined in this patent application are positioned to enable scalable manufacturing because they require fewer synthetic steps than current methods, utilize cost effective and readily available starting materials, and leverage chemical manufacturing processes that are already standard practice in the pharmaceutical industry. Telescope’s synthetic methods are therefore well-poised for compatibility with the standards of current Good Manufacturing Practices (cGMP) ultimately required for pharmaceutical deployment.

Jason Hein, CEO of Telescope, noted, “the demand for pharmaceutical-grade psilocybin and psychedelic tryptamines is rising. We are seeing increased numbers of trials and studies advancing these compounds along the drug development pipeline, but there has been relatively little focus on how these molecules will be reliably produced at a large scale. Telescope’s patent represents a significant milestone in addressing the impending manufacturing bottleneck.”

The synthetic processes described in the PCT application are not limited to the production of psilocybin, but enable access to a wide variety of tryptamines and can be easily adapted to produce specific derivatives. Derivatives are currently being explored by drug development companies seeking to tune the predictability, potency, or pharmacokinetic profiles of psychedelic therapeutics. Telescope’s intellectual property portfolio is therefore flexible and amenable to changing demands as different molecules are targeted throughout pharmaceutical development in the psychedelic space. Indeed, while developing proprietary synthesis processes, Telescope has discovered new molecules (Novel Chemical Entities; “NCEs“) that may become candidates for preclinical development. These NCEs are also captured within the PCT application.

“We’re very pleased with Telescope’s research results this year,” added Hein. “The Company is set up very well to continue developing our intellectual property portfolio and bringing our discoveries closer to deployment.”

About Telescope

Telescope is a chemical technology company developing scalable, widely deployable synthetic processes to manufacture pharmaceuticals for the treatment of mental health. The Company develops new enabling technology to achieve these goals, including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Research and development efforts are currently focused on medicines from the under-utilized tryptamine class of compounds, leveraging innovative process chemistry both to optimize synthetic procedures and access novel molecules. Our aim is to bring modern chemical solutions to meet the most serious challenges in human health.

 



Source link

Continue Reading

Psychedelics

(NIDA) Director Nora Volkow tells Marijuana Moment – the “train has left the station” on psychedelics.

Published

on

By


Marijuana Moment write

A top federal drug official says the “train has left the station” on psychedelics.

National Institute on Drug Abuse (NIDA) Director Nora Volkow said people are going to keep using substances such as psilocybin—especially as the reform movement expands and there’s increased attention being drawn to the potential therapeutic benefits—and so researchers and regulators will need to keep up.

The comments came at a psychedelics workshop Volkow’s agency cohosted with the National Institute of Mental Health (NIMH) last week.

The NIDA official said that, to an extent, it’s been overwhelming to address new drug trends in the psychedelics space. But at the same time, she sees “an incredible opportunity to also modify the way that we are doing things.”

“What is it that the [National Institutes of Health] can do to help accelerate research in this field so that we can truly understand what are the potentials, and ultimately the application, of interventions that are bought based on psychedelic drugs?” Volkow said.

Full report

Top Federal Drug Official Says ‘Train Has Left The Station’ On Psychedelics As Reform Movement Spreads



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media